Medicare Enrolled
Dr. Kenneth Carnes, M.D.
Neurology · Raleigh, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Carnes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carnes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Carnes
Dr. Kenneth Carnes is a neurology specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Carnes performed 19,749 Medicare services across 931 unique beneficiaries.
Between the years covered by Open Payments, Dr. Carnes received a total of $20,883 from 99 pharmaceutical and/or device companies across 1186 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Carnes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NC
$20,883 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,749
Medicare services
Top 5% in NC for neurology
931
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~987 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, natalizumab, 1 mg | 11,400 | $19 | $35 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3,610 | $38 | $90 |
| MRI contrast dye injection (gadobutrol) | 3,380 | $0 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
654 | $58 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
209 | $106 | $380 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
76 | $15 | $166 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
72 | $4 | $15 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
67 | $45 | $228 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
62 | $92 | $1,980 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
51 | $81 | $510 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
48 | $45 | $240 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
25 | $61 | $160 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
24 | $96 | $480 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
21 | $151 | $2,235 |
| Lumbar puncture for diagnostic test A procedure to remove cerebrospinal fluid from the lower back for diagnostic testing. |
18 | $95 | $593 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
17 | $68 | $1,518 |
| MRI of lower spine, without contrast A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine. |
15 | $84 | $1,574 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
94.4% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,883
Total received (2018-2024)
Avg $2,983/year across 7 years
Top 14% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,186
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,559 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$324 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,794
2023
$3,846
2022
$3,616
2021
$1,421
2020
$447
2019
$2,122
2018
$3,638
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$894
ABBVIE INC.
$747
Alexion Pharmaceuticals, Inc.
$422
Lundbeck LLC
$359
EMD Serono, Inc.
$253
Amgen Inc.
$250
Lilly USA, LLC
$247
Neurocrine Biosciences, Inc.
$240
PFIZER INC.
$195
Novartis Pharmaceuticals Corporation
$171
Biogen, Inc.
$159
Grifols USA, LLC
$154
ARGENX US, INC.
$142
TG Therapeutics, Inc.
$139
BANNER LIFE SCIENCES, LLC
$120
Axsome Therapeutics, Inc.
$93
Sumitomo Pharma America, Inc.
$78
Avadel CNS Pharmaceuticals, LLC
$77
Eisai Inc.
$73
Teva Pharmaceuticals USA, Inc.
$73
Neurelis, Inc.
$71
Aucta Pharmaceuticals, Inc.
$62
ANI Pharmaceuticals, Inc.
$61
CATALYST PHARMACEUTICALS, INC.
$59
Celgene Corporation
$55
Vanda Pharmaceuticals Inc.
$45
Mallinckrodt Hospital Products Inc.
$43
Kyowa Kirin, Inc.
$41
CSL Behring
$37
Averitas Pharma Inc.
$36
Alnylam Pharmaceuticals Inc.
$36
Acorda Therapeutics, Inc
$35
Ipsen Biopharmaceuticals, Inc
$35
Genentech USA, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$31
ACADIA Pharmaceuticals Inc
$30
NEUROPACE, INC.
$25
HARMONY BIOSCIENCES LLC
$25
Merz Pharmaceuticals, LLC
$24
Boston Scientific Corporation
$21
Ultragenyx Pharmaceutical Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
SK Life Science, Inc.
$18
AstraZeneca Pharmaceuticals LP
$17
Amneal Pharmaceuticals LLC
$15
Top 3 companies account for 35.6% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,589
Novartis Pharmaceuticals Corporation
$1,175
ABBVIE INC.
$1,174
Teva Pharmaceuticals USA, Inc.
$1,061
AbbVie Inc.
$1,060
Amgen Inc.
$980
Alexion Pharmaceuticals, Inc.
$947
GENZYME CORPORATION
$821
Lundbeck LLC
$677
Biogen, Inc.
$667
Medtronic USA, Inc.
$655
IMPEL PHARMACEUTICALS INC.
$558
Grifols USA, LLC
$482
Lilly USA, LLC
$463
PFIZER INC.
$409
EMD Serono, Inc.
$404
Neurocrine Biosciences, Inc.
$385
Acorda Therapeutics, Inc
$339
Janssen Pharmaceuticals, Inc
$306
Eisai Inc.
$281
Genentech USA, Inc.
$254
Avanir Pharmaceuticals, Inc.
$205
Amneal Pharmaceuticals LLC
$193
ARGENX US, INC.
$186
Neurelis, Inc.
$183
Biohaven Pharmaceutical Holding Company Ltd.
$179
Sunovion Pharmaceuticals Inc.
$178
SK Life Science, Inc.
$176
TG THERAPEUTICS, INC.
$168
Allergan Inc.
$161
UPSHER-SMITH LABORATORIES LLC
$150
Axsome Therapeutics, Inc.
$146
CSL Behring
$145
Avion Pharmaceuticals
$140
TG Therapeutics, Inc.
$139
BOSTON SCIENTIFIC CORPORATION
$135
Sumitomo Pharma America, Inc.
$131
ACADIA Pharmaceuticals Inc
$131
BANNER LIFE SCIENCES, LLC
$120
EISAI INC.
$118
Merz North America, Inc.
$113
CATALYST PHARMACEUTICALS, INC.
$112
Celgene Corporation
$110
MDD US Operations, LLC
$106
Avadel CNS Pharmaceuticals, LLC
$105
Biohaven Pharmaceuticals, Inc.
$102
JAZZ PHARMACEUTICALS INC.
$96
ARBOR PHARMACEUTICALS, INC.
$95
Mitsubishi Tanabe Pharma America, Inc.
$95
Otsuka America Pharmaceutical, Inc.
$91
Corium, LLC
$90
Supernus Pharmaceuticals, Inc.
$84
Kyowa Kirin, Inc.
$84
Banner Life Sciences, LLC
$82
Assertio Therapeutics, Inc.
$79
ASSERTIO THERAPEUTICS, Inc.
$77
Mallinckrodt Hospital Products Inc.
$74
Alnylam Pharmaceuticals Inc.
$73
AQUESTIVE THERAPEUTICS, INC.
$69
AstraZeneca Pharmaceuticals LP
$69
Merz Pharmaceuticals, LLC
$68
Upsher-Smith Laboratories LLC
$67
Bausch Health US, LLC
$65
SANOFI-AVENTIS U.S. LLC
$65
Promius Pharma LLC
$64
Adamas Pharmaceuticals, Inc.
$62
Aucta Pharmaceuticals, Inc.
$62
Allergan, Inc.
$62
ANI Pharmaceuticals, Inc.
$61
Mallinckrodt LLC
$58
Merck Sharp & Dohme LLC
$51
Collegium Pharmaceutical, Inc.
$48
Ipsen Biopharmaceuticals, Inc
$47
Vanda Pharmaceuticals Inc.
$45
Octapharma USA, Inc.
$40
GE HEALTHCARE
$37
Averitas Pharma Inc.
$36
Microtransponder, Inc.
$35
Cala Health, Inc.
$33
Boston Scientific Corporation
$32
IDORSIA PHARMACEUTICALS US INC
$31
LivaNova USA, Inc.
$26
Strongbridge US INC.
$26
NEUROPACE, INC.
$25
GE HealthCare
$25
HARMONY BIOSCIENCES LLC
$25
Zyla Life Sciences
$23
Ultragenyx Pharmaceutical Inc.
$21
Catalyst Pharmaceuticals, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
GRT US Holding, Inc.
$18
Azurity Pharmaceuticals, Inc.
$17
Arbor Pharmaceuticals, Inc.
$16
Impax Laboratories, Inc.
$15
Greenwich Biosciences, Inc.
$13
Currax Pharmaceuticals LLC
$13
Mallinckrodt Enterprises LLC
$13
Egalet US Inc
$12
Kowa Pharmaceuticals America, Inc.
$12
Top 3 companies account for 18.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADAPTIVESTIM · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CALA TRIO · COMIRNATY · COPAXONE · Cambia · DYSPORT · Dayvigo · Dhivy · Dojolvi · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EVUSHELD · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GENERAL DBS · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · LEMTRADA · LEQEMBI · LUMRYZ · LYRICA · LYVISPAH · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OXAYDO · Ocrevus · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · SPRIX · SYMPAZAN · Seglentis · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WaveWriter Alpha Prime 16 · XEOMIN · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZORVOLEX · Zembrace · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
115
Per 100K population
10.0
County median income
$101,763
Nearest hospital
REX HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Carnes is a mixed practice specialist, with above-average Medicare volume (top 5% in NC), with low-engagement industry engagement in the top 14% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Carnes experienced with injection, natalizumab, 1 mg?
Based on Medicare claims data, Dr. Carnes performed 11,400 injection, natalizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carnes receive payments from pharmaceutical companies?
Yes. Dr. Carnes received a total of $20,883 from 99 companies across 1,186 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carnes's costs compare to other neurologists in Raleigh?
Dr. Carnes's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carnes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Raleigh
Browse neurologists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology